Abstract：Objective: To investigate the changes and significance of T lymphocyte subsets, B cells, and natural killer (NK) cells in infertility patients with high-risk cervical human papilloma (HPV) infection. Methods: The clinical data of 1,150 infertility patients with cervical high-risk HPV infection (study group) and 580 HPV-negative infertility patients (control group) who were treated in the gynecology department at the hospital between November 2019 and October 2020 were collected retrospectively. The changes in T lymphocyte subsets, B cells, and NK cells were compared between the two groups. The relationship of the above-mentioned indicators with subtypes of HPV infection and grades of cervical lesions was analyzed. Results: There were no significant differences in the proportions of CD3+ and B cells between the two groups (P>0.05). The proportions of CD4+, CD4+/CD8+, and NK cells in the study group were lower than those in the control group, and the proportion of CD8+ was higher than that in the control group (P<0.05). In the study group, the proportion of HPV 16/18 infected patients was higher than patients infected with other subtypes, and the proportion of HPV 16/18 was significantly different in patients with different grades of HPV infection (P<0.05). The proportions of CD4+, CD4+/CD8+, and NK cells in HPV 16/18 infected patients were lower than those in patients infected with other subtypes, and the proportion of CD8+ was higher than that in patients infected with other subtypes (P<0.05). The proportions of CD3+ and B cells showed no significant differences between patients infected with different subtypes of HPV (P>0.05). With the progression of cervical lesions, the proportions of CD4+, CD4+/CD8+, and NK cells decreased, while the proportion of CD8+ increased (P<0.05), but no significant changes in the proportions of CD3+ and B cells were observed (P>0.05). Conclusion: High-risk HPV-infected infertility patients are accompanied by a certain degree of immune dysfunction. Clinically, changes in the proportions of T lymphocyte subsets, B cells, and NK cells can be detected to provide an objective basis for clinical assessment of HPV subtypes and the progression of cervical lesions.
李荣, 高晓雨, 王鑫, 马媛, 阎颖. 宫颈高危HPV感染不孕症患者T淋巴细胞亚群B细胞及NK细胞水平变化及意义分析[J]. 河北医学, 2023, 29(10): 1659-1664.
LI Rong, GAO Xiaoyu, WANG Xin, et al. Changes and Significance of T Lymphocyte Subsets, B Cells and NK Cells in Infertility Patients with Cervical High-Risk HPV Infection. HeBei Med, 2023, 29(10): 1659-1664.
[1] Shin J O,Son J H,Lee J,et al.Nonavalent human papilloma virus vaccine for the treatment of multiple recalcitrant warts:an open label study[J].Am Acad Dermatol,2022,86(4):940-941. [2] 姚小艳,周芳芳,马为为.HPV基因分型联合TCT筛查宫颈病变的价值分析[J].河北医学,2021,27(2):222-227. [3] Kamal M,Lameiras S,Deloger M,et al.Human papilloma virus (HPV) integration signature in cervical cancer:identification of MACROD2 gene as HPV hot spot integration site[J].Br Cancer,2021,124(4):777-785. [4] 何春雷,陈洁,金凯黎,等.妇女高危HPV亚型分布与宫颈病变的相关性[J].临床与病理杂志,2022,42(12):2977-2982. [5] 李燕华,周少雄,薛家权,等.高危型HPV感染不孕症女性患者外周血淋巴细胞亚群水平[J].广东医学,2020,41(3):257-260. [6] Jakobsen J K,Toft B G,Krarup K P,et al.Human papilloma virus prevalence in penile cancer:a multicenter study from Denmark (DaPeCa-6)[J].Int Urol,2021,28(4):466-468. [7] 武亚丽,黄怡,刘转子,等.育龄期女性阴道微生态失调与高危型HPV感染的关系[J].海南医学,2021,32(16):2088-2090. [8] 沈红雁,周秀芬,张青,等.HPV感染对宫颈上皮内瘤样变患者阴道免疫细胞及炎性因子表达的影响[J].中华医院感染学杂志,2020,30(16):2507-2510. [9] Christianto S,Li K Y,Huang T H,et al.The prognostic value of human papilloma virus infection in oral cavity squamous cell carcinoma:a meta-analysis[J].Laryngoscope,2022,132(9):1760-1770. [10] Sullivan-Blum Z C,Brophy M,Didde R,et al.PrEP patient attitudes,beliefs and perceived barriers surrounding HPV vaccination:a qualitative study of semistructured interviews with PrEP patients in primary care clinics in Kansas and Missouri[J].BMJ open,2022,12(4):58510.
2023, Vol. 29 
冀公网安备13080202000677号